Infinity Pharmaceuticals Inc. (INFI), Oncothyreon Inc (USA) (ONTY), Synageva BioPharma Corp (GEVA): Three Horrendous Healthcare Stocks This Week

Some of Synageva BioPharma Corp (NASDAQ:GEVA)’s woes can be seen in its quarterly results announced on May 7. The biotech lost nearly twice as much as it did in the same period of 2012. J.P. Morgan also downgraded the stock last week over concerns that Synageva BioPharma Corp (NASDAQ:GEVA) could have problems enrolling patients for its late-stage clinical study of sebelipase alfa for treating adults with late-onset Lysosomal Acid Lipase Deficiency.

A good week
You know it’s been a good week for the market when any of the most horrendous health-care stocks drop by only a single-digit percentage. There usually are more stocks dropping by 15% or greater than we have room to discuss. The opposite was true for this week, with plenty of health-care stocks gaining by 15% or more.

We shouldn’t get used to it, though. There will be plenty of horrendous weeks and truly horrendous stocks in the months ahead.

The article 3 Horrendous Health-Care Stocks This Week originally appeared on Fool.com and is written by Keith Speights.

Fool contributor Keith Speights has no position in any stocks mentioned. The Motley Fool recommends Gilead Sciences.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.